Mount Sinai Innovation Partners Mount Sinai Innovation Partners Mount Sinai Innovation Partners Mount Sinai Innovation Partners
  • Get Started
    • Disclose a Technology
    • Request an Agreement
    • Search Technologies
    • Contact Your Representative
  • About Us
    • Our Mission
    • Our Impact
      • Technologies
      • Startup Companies
    • Our Team
    • Our Partners
  • Programs
    • Elementa Labs
    • Entrepreneurship Program
    • Fellows Program
    • i3 Funding
      • i3 Prism
      • i3 Genesis
      • i3 Accelerator
    • External Collaborations
  • Resources
    • Innovation Guide
    • Drug Discovery Guide
    • Local Resources
    • Institutional Policies
    • Frequently Asked Questions (FAQs)
  • Discover More
    • News
    • Events
    • Videos
  • Careers
    • Explore Career Opportunities
  • Mount Sinai Health System
    • MountSinai.org
    • Search Faculty
    • Clinical Trials
    • Donations & Gifts
    • Faculty Consulting
Announcements

Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis

September 10, 2013

September 10, 2013 –  Mount Sinai Innovation Partners (MSIP), part of the Icahn School of Medicine at Mount Sinai, has granted an exclusive license to  Plexcera Therapeutics, LLC  to commercially develop recombinant human acid ceramidase (rhAC) to treat diseases caused by genetic or …

Read full post
Announcements

Mount Sinai and Exosome Diagnostics Partner to Accelerate Translation of Body Fluid Molecular Diagnostics to Overcome Limitations of Tissue Biopsy in Areas of Critical Unmet Medical Needs

August 21, 2013

August 21, 2013 – The Icahn School of Medicine at Mount Sinai and Exosome Diagnostics today announced a collaboration on the research and development of real-time nucleic acid-based body-fluid diagnostics to advance personalized medicine. Exosome will provide technical and development support to Mount Sinai researchers along with early …

Read full post
Announcements

Two Mount Sinai Researchers Named “Inventors of the Year” by the New York Intellectual Property Law Association

June 28, 2013

June 28, 2013 – The New York Intellectual Property Law Association (NYIPLA) has honored two researchers at the Icahn School of Medicine at Mount Sinai with its 2013 Inventor of the Year Award in recognition of their work on Niemann-Pick Disease, or NPD. The …

Read full post
Announcements

Mount Sinai Researchers Succeed in Programming Blood Forming Stem Cells

June 14, 2013

June 14, 2013 – By transferring four genes into mouse fibroblast cells, researchers at the Icahn School of Medicine at Mount Sinai have produced cells that resemble hematopoietic stem cells, which produce millions of new blood cells in the human body every day. These findings …

Read full post
Announcements, Blue Mountain

Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles

May 24, 2013

May 24, 2013 – The Icahn School of Medicine at Mount Sinai has granted Cellular Dynamics International (CDI) exclusive license rights  to commercially develop cardiomyocyte progenitors for in vivo cell therapy and regenerative medicine applications. These cells are capable of further differentiation into the multiple cell …

Read full post
Announcements

Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria

May 17, 2013

May 17, 2013 – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of porphyria including acute intermittent porphyria (AIP). The …

Read full post
Announcements

Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh To Collaborate On Clinical Studies For Mucopolysaccharidoses

May 15, 2013

May 15, 2013 – The Icahn School of Medicine at Mount Sinai has signed an agreement with bene pharmaChem GmbH to collaborate to conduct clinical studies of pentosan polysulfate (PPS) in patients with mucopolysaccharidoses (MPS). The company, based in Germany, is the sole producer of pharmaceutical …

Read full post
Announcements, Blue Mountain

Mount Sinai Invents Gene Signature to Identify Individuals with Cirrhosis at High-Risk for Liver Cancer

April 17, 2013

April 17, 2013 – Researchers at the Icahn School of Medicine at Mount Sinai have developed the first-ever gene test that could be used to identify patients with cirrhosis who are at highest risk of developing the most common type of liver cancer, …

Read full post
Announcements, Blue Mountain

The Icahn School of Medicine at Mount Sinai Partners with Genisphere to Develop Rapid, High-Throughput Allergy Test

January 31, 2013

January 31, 2013 – The Icahn School of Medicine at Mount Sinai and Genisphere have agreed to jointly develop a new allergy test that will quickly and effectively characterize patients’ food allergies. The peptide-bead-based test will be high-throughput, semi-automatic and accurate, surpassing …

Read full post
Announcements

Anti-Cancer Activity Drug IRX4204 Shows Promise as a Potential Disease-Modifying Agent for Alzheimer’s Disease

September 13, 2012

September 13, 2012 – New research presented today at the 6th Neurodegenerative Conditions Research and Development Conference in San Francisco, California demonstrates the role of the investigational compound IRX4204 in alleviating cognitive decline in animal models of Alzheimer’s disease. The presentation entitled “Investigation …

Read full post
  • 1
  • …
  • 8
  • 9
  • 10

Mount Sinai Health System

The Mount Sinai Health System is an integrated health care system providing exceptional medical care to our local and global communities.

Read More

Contact MSIP

MSIPInfo@mssm.edu

For technology and research inquiries: visit Contact Your Representative or Contact MSIP

 

Follow Us

  • LinkedIn
  • Facebook
  • X
  • YouTube

Stay Updated

Sign up for the MSIP mailing list

Mount Sinai Innovation Partners © Copyright 2025

  • Privacy Policy
  • Terms & Conditions
  • Non-Discrimination Notice
  • Get Started
    • Disclose a Technology
    • Request an Agreement
    • Search Technologies
    • Contact Your Representative
  • About Us
    • Our Mission
    • Our Impact
      • Technologies
      • Startup Companies
    • Our Team
    • Our Partners
  • Programs
    • Elementa Labs
    • Entrepreneurship Program
    • Fellows Program
    • i3 Funding
      • i3 Prism
      • i3 Genesis
      • i3 Accelerator
    • External Collaborations
  • Resources
    • Innovation Guide
    • Drug Discovery Guide
    • Local Resources
    • Institutional Policies
    • Frequently Asked Questions (FAQs)
  • Discover More
    • News
    • Events
    • Videos
  • Careers
    • Explore Career Opportunities
  • Mount Sinai Health System
    • MountSinai.org
    • Search Faculty
    • Clinical Trials
    • Donations & Gifts
    • Faculty Consulting

Hit enter to search or ESC to close